The global Monoclonal Antibody Therapy Market size was USD 157.33 billion in 2020. The market is projected to grow from USD 178.50 billion in 2021 to USD 451.89 billion in 2028 at a CAGR of 14.1% in the 2021-2028 period. This information is published by Fortune Business Insights™ in its report titled, “Monoclonal Antibody Therapy Market, 2021-2028.”
The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.
Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/sample/monoclonal-antibody-therapy-market-102734
We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of coronavirus outbreak across industries to help you prepare for the future.
Competitive Landscape-
Improvements in Regulatory Approvals and the Introduction of New Therapies to Fuel Innovation
Regulatory agencies’ approval of monoclonal antibodies favors the launch of novel therapeutics, which is expected to fuel Monoclonal Antibody Therapy market growth over the forecast period. For instance, the US Food and Drug Administration (FDA) granted avelumab (BAVENCIO, EMD Serono, Inc.), a human monoclonal antibody therapy, accelerated the approval for the treatment of metastatic Merkel cell carcinoma, a rare disease. Similarly, the US FDA granted TECENTRIQ (atezolizumab), a humanized, engineered monoclonal antibody, fast-track approval for cancer treatment.
List of the Companies Operating in the Market:
- AbbVie Inc. (Illinois, United States)
- Merck & Co., Inc. (New Jersey, United States)
- F.Hoffmann-La Roche Ltd. (Basel, Switzerland)
- Bristol-Myers Squibb Company (New York, United States)
- Johnson & Johnson Services, Inc. (New Jersey, United States)
- Daiichi Sankyo Company, Limited (Tokyo, Japan)
- Novartis AG (Basel, Switzerland)
- Alexion Pharmaceuticals, Inc. (Massachusetts, United States)
- Amgen Inc. (California, United States)
Get your Customized Research Report: https://www.fortunebusinessinsights.com/enquiry/customization/monoclonal-antibody-therapy-market-102734
Some major points from Table of Content:
- Introduction
- Research Scope
- Market Segmentation
- Research Methodology
- Definitions and Assumptions
- Executive Summary
- Market Dynamics
- Market Drivers
- Market Restraints
- Market Opportunities
- Key Insights
- Prevalence of Major Diseases – For Key Countries
- Patent Snapshot
- Pipeline Analysis
- New Product Launches
- Key Industry Developments – Mergers, Acquisitions and Partnerships
- Key Industry Trends
- Global Monoclonal Antibody Therapy Market Analysis, Insights and Forecast, 2017-2028
- Key Findings / Summary
- Market Analysis, Insights and Forecast – By Type
- Human Monoclonal Antibody
- Humanized Monoclonal Antibody
- Chimeric Monoclonal Antibody
- Murine Monoclonal Antibody
- Market Analysis, Insights and Forecast – By Application
- Cancer
- Autoimmune Diseases
- Others
- Market Analysis, Insights and Forecast – By Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Market Analysis, Insights and Forecast – By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
- North America Monoclonal Antibody Therapy Market Analysis, Insights and Forecast, 2017-2028
- Key Findings / Summary
- Market Analysis, Insights and Forecast – By Type
- Human Monoclonal Antibody
- Humanized Monoclonal Antibody
- Chimeric Monoclonal Antibody
- Murine Monoclonal Antibody
- Market Analysis, Insights and Forecast – By Application
- Cancer
- Autoimmune Diseases
- Others
- Market Analysis, Insights and Forecast – By Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Market Analysis, Insights and Forecast – By Country
- U.S.
- Canada
- Europe Monoclonal Antibody Therapy Market Analysis, Insights and Forecast, 2017-2028
- Key Findings / Summary
- Market Analysis, Insights and Forecast – By Type
- Human Monoclonal Antibody
- Humanized Monoclonal Antibody
- Chimeric Monoclonal Antibody
- Murine Monoclonal Antibody
- Market Analysis, Insights and Forecast – By Application
- Cancer
- Autoimmune Diseases
- Others
- Market Analysis, Insights and Forecast – By Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Market Analysis, Insights and Forecast – By Countries/ Sub-region
- U.K.
- Germany
- France
- Spain
- Italy
- Scandinavia
- Rest of Europe
- Asia Pacific Monoclonal Antibody Therapy Market Analysis, Insights and Forecast, 2017-2028
- Key Findings / Summary
- Market Analysis, Insights and Forecast – By Type
- Human Monoclonal Antibody
- Humanized Monoclonal Antibody
- Chimeric Monoclonal Antibody
- Murine Monoclonal Antibody
- Market Analysis, Insights and Forecast – By Application
- Cancer
- Autoimmune Diseases
- Others
- Market Analysis, Insights and Forecast – By Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Market Analysis, Insights and Forecast – By Countries/ Sub-region
- Japan
- China
- India
- Australia
- Southeast Asia
- Rest of Asia Pacific
- Latin America Monoclonal Antibody Therapy Market Analysis, Insights and Forecast, 2017-2028
- Key Findings / Summary
- Market Analysis, Insights and Forecast – By Type
- Human Monoclonal Antibody
- Humanized Monoclonal Antibody
- Chimeric Monoclonal Antibody
- Murine Monoclonal Antibody
- Market Analysis, Insights and Forecast – By Application
- Cancer
- Autoimmune Diseases
- Others
- Market Analysis, Insights and Forecast – By Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Market Analysis, Insights and Forecast – By Countries/ Sub regions
- Brazil
- Mexico
- Rest of Latin America
Continued…
About Us:
Fortune Business Insights™ delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. We tailor novel solutions for our clients, assisting them to address various challenges distinct to their businesses. Our aim is to empower them with holistic market intelligence, providing a granular overview of the market they are operating in.
Contact Us:
Fortune Business Insights™ Pvt. Ltd.
Pune – 411045, Maharashtra, India.
Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245